BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 25392853)

  • 1. Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation.
    Pignatelli P; Pastori D; Carnevale R; Farcomeni A; Cangemi R; Nocella C; Bartimoccia S; Vicario T; Saliola M; Lip GY; Violi F
    Thromb Haemost; 2015 Mar; 113(3):617-24. PubMed ID: 25392853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial dysfunction and oxidative stress in children with sleep disordered breathing: role of NADPH oxidase.
    Loffredo L; Zicari AM; Occasi F; Perri L; Carnevale R; Angelico F; Del Ben M; Martino F; Nocella C; Savastano V; Cesoni Marcelli A; Duse M; Violi F
    Atherosclerosis; 2015 May; 240(1):222-7. PubMed ID: 25805361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation.
    Pastori D; Pignatelli P; Farcomeni A; Cangemi R; Hiatt WR; Bartimoccia S; Nocella C; Vicario T; Bucci T; Carnevale R; Lip GY; Violi F
    Am Heart J; 2015 Sep; 170(3):490-7.e1. PubMed ID: 26385032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation.
    Ferro D; Loffredo L; Polimeni L; Fimognari F; Villari P; Pignatelli P; Fuster V; Violi F
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2763-8. PubMed ID: 17901373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and hypercholesterolemia are associated with NOX2 generated oxidative stress and arterial dysfunction.
    Loffredo L; Martino F; Carnevale R; Pignatelli P; Catasca E; Perri L; Calabrese CM; Palumbo MM; Baratta F; Del Ben M; Angelico F; Violi F
    J Pediatr; 2012 Dec; 161(6):1004-9. PubMed ID: 22727869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different behaviour of NOX2 activation in patients with paroxysmal/persistent or permanent atrial fibrillation.
    Cangemi R; Celestini A; Calvieri C; Carnevale R; Pastori D; Nocella C; Vicario T; Pignatelli P; Violi F
    Heart; 2012 Jul; 98(14):1063-6. PubMed ID: 22628539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nox2 up-regulation is associated with an enhanced risk of atrial fibrillation in patients with pneumonia.
    Violi F; Carnevale R; Calvieri C; Nocella C; Falcone M; Farcomeni A; Taliani G; Cangemi R;
    Thorax; 2015 Oct; 70(10):961-6. PubMed ID: 26123660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
    Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
    Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of vitamin E are associated with early recurrence of atrial fibrillation after electric cardioversion.
    Ferro D; Franciosa P; Cangemi R; Carnevale R; Pignatelli P; Loffredo L; Perri L; Catasca E; Violi F
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):327-33. PubMed ID: 22362890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.
    Chan YH; Yiu KH; Lau KK; Yiu YF; Li SW; Lam TH; Lau CP; Siu CW; Tse HF
    Atherosclerosis; 2014 Dec; 237(2):504-13. PubMed ID: 25463082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global left ventricular longitudinal systolic strain as a major predictor of cardiovascular events in patients with atrial fibrillation.
    Su HM; Lin TH; Hsu PC; Lee WH; Chu CY; Lee CS; Voon WC; Lai WT; Sheu SH
    Heart; 2013 Nov; 99(21):1588-96. PubMed ID: 24014280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.
    Atanassova PA; Chalakova NT; Dimitrov BD
    Cerebrovasc Dis; 2008; 25(3):225-33. PubMed ID: 18216464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged atrium electromechanical interval is associated with stroke in patients with atrial fibrillation after catheter ablation.
    Chao TF; Lin YJ; Tsao HM; Chang SL; Lo LW; Hu YF; Tuan TC; Li CH; Chang HY; Wu TJ; Yu WC; Chen SA
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):375-80. PubMed ID: 23252831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the Coexistence of Chronic Obstructive Pulmonary Disease and Atrial Fibrillation Affect Nox2 Activity and Urinary Isoprostanes Excretion?
    Pastori D; Andreozzi P; Carnevale R; Bartimoccia S; Limaj S; Melandri S; Brunori M; Spallacci G; Violi F; Pignatelli P
    Antioxid Redox Signal; 2019 Oct; 31(11):786-790. PubMed ID: 31250672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
    Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation.
    Aulin J; Siegbahn A; Hijazi Z; Ezekowitz MD; Andersson U; Connolly SJ; Huber K; Reilly PA; Wallentin L; Oldgren J
    Am Heart J; 2015 Dec; 170(6):1151-60. PubMed ID: 26678637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroke prediction using mean platelet volume in patients with atrial fibrillation.
    Ha SI; Choi DH; Ki YJ; Yang JS; Park G; Chung JW; Koh YY; Chang KS; Hong SP
    Platelets; 2011; 22(6):408-14. PubMed ID: 21599611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of the CHADS
    Tabata N; Yamamoto E; Hokimoto S; Yamashita T; Sueta D; Takashio S; Arima Y; Izumiya Y; Kojima S; Kaikita K; Matsui K; Fujimoto K; Sakamoto K; Shimomura H; Tsunoda R; Hirose T; Nakamura N; Sakaino N; Nakamura S; Yamamoto N; Matsumura T; Kajiwara I; Koide S; Sakamoto T; Nakao K; Oshima S; Tsujita K;
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.